Pulmonary Outcomes on Patients With Lung Fibrosis

South Valley University

Status: Active, not recruiting

Conditions: Lung Fibrosis

Treatments: Other: Routine medical care; Other: Pulmonary rehabilitation

Study type: Interventional

Funder types: Other

Identifiers

NCT07088185

P.T_INT_11/2024_554

Details and patient eligibility

About

The pulmonary fibrosis is lung disease that occurs when lung tissue become damaged and scarred. The objectives of treatment are to improve symptoms and quality of life, and slow disease progression.

Full description

This study will include 60 patients with pulmonary fibrosis from both gender who are aged from 35 - 55 years old.This study will be randomized controlled trial.

Enrollment: 60 estimated patients

Sex: All

Ages: 35 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• both gender.
• patients with cystic fibrosis.

Exclusion criteria

• severe chronic disorders.
• heart failure
• respiratory failure.
• age less than 35 or older than 55 years old.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

Control group

Other group

Description:

This group will recieve only routine medical care.

Treatment:

Other: Routine medical care

Pulmonary rehabilitation group

Other group

Description:

Pulmonary rehabilitation ( breathing exercises, posture drainage, additive techniques with postural drainage like vibration,shaking and percussion, active cycle of breathing techniques, autogenic drainage) plus routine medical care.

Treatment:

Other: Pulmonary rehabilitation

Other: Routine medical care